Through pioneering research in tumor metabolism, Jeff Geschwind advances liver cancer therapy using Cone Beam CT-guided TACE. His methods improve visualization of tumor feeders, ensure accurate embolization, and help clinicians adapt treatment in real time. This integrated strategy supports more effective and personalized interventions for patients with hepatocellular carcinoma. https://www.bumc.bu.edu/camed/offices-services/alumni/alumni-recognition-resources/alumni-awards-submission/past-recipients-of-the-alumni-awards/jean-francois-jeff-geschwind-m-d-91-2011-distinguished-alumnus-award/